| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |